Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Net Income PerformanceStrong
Percentile Rank93
3Y CAGR+1.3%
5Y CAGR+5.1%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+1.3%/yr
vs +15.4%/yr prior
5Y CAGR
+5.1%/yr
Recent deceleration
Acceleration
-14.2pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.50B | +2.1% |
| 2024 | $4.41B | +11.6% |
| 2023 | $3.95B | -8.9% |
| 2022 | $4.34B | -46.3% |
| 2021 | $8.08B | +129.9% |
| 2020 | $3.51B | +66.0% |
| 2019 | $2.12B | -13.4% |
| 2018 | $2.44B | +104.0% |
| 2017 | $1.20B | +33.8% |
| 2016 | $895.52M | - |